2023 Scientific Sessions

State of the Art: SHD Year in Review

Structural heart disease has had a big year, and there’s more come. Hear about major recent developments and studies in the pipeline for TAVR, mitral, tricuspid, LAAO, and novel device classes.

This session is not certified for CME credit.

State of the Art: Development of TAVR and Future Directions
Henning Rud Rud Andersen, Aarhus University Hospital, Department of Cardiology - Research, Højbjerg, Denmark
State of the Art: Transcatheter Mitral Year in Review and Future Directions
David G. Rizik, M.D., MSCAI, HonorHealth Heart Group, Scottsdale, AZ
State of the Art: LAAO Year in Review and Future Directions
Paul Fiorilli, M.D., Hospital of the University of Pennsylvania, Haddonfield, NJ